Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascend Wellness Holdings (AAWH) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Ascend Wellness Holdings (AAWH) over the last 6 years, with Q3 2025 value amounting to $81.1 million.

  • Ascend Wellness Holdings' Cost of Revenue fell 1714.19% to $81.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $344.6 million, marking a year-over-year decrease of 951.9%. This contributed to the annual value of $377.4 million for FY2024, which is 382.95% up from last year.
  • Per Ascend Wellness Holdings' latest filing, its Cost of Revenue stood at $81.1 million for Q3 2025, which was down 1714.19% from $85.9 million recorded in Q2 2025.
  • Ascend Wellness Holdings' 5-year Cost of Revenue high stood at $100.0 million for Q2 2024, and its period low was $36.5 million during Q1 2021.
  • For the 5-year period, Ascend Wellness Holdings' Cost of Revenue averaged around $77.1 million, with its median value being $81.1 million (2025).
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 26991.52% in 2021, then tumbled by 1714.19% in 2025.
  • Quarter analysis of 5 years shows Ascend Wellness Holdings' Cost of Revenue stood at $57.7 million in 2021, then rose by 22.42% to $70.6 million in 2022, then surged by 31.21% to $92.6 million in 2023, then dropped by 3.76% to $89.1 million in 2024, then dropped by 8.98% to $81.1 million in 2025.
  • Its last three reported values are $81.1 million in Q3 2025, $85.9 million for Q2 2025, and $88.4 million during Q1 2025.